Mirador Therapeutics, Inc.
Mirador Therapeutics is focused on discovering and developing precision medicines for immune-mediated inflammatory and fibrotic diseases using its Mirador360™ engine, which harnesses biology, multi-modal data, AI, and advanced analytics.
Funding history
About Mirador Therapeutics, Inc.
How much funding has Mirador Therapeutics, Inc. raised?
Mirador Therapeutics, Inc. has raised $413.0M in total funding.
Where is Mirador Therapeutics, Inc. headquartered?
Mirador Therapeutics, Inc. is headquartered in San Diego, CA.
What does Mirador Therapeutics, Inc. do?
Mirador Therapeutics is focused on discovering and developing precision medicines for immune-mediated inflammatory and fibrotic diseases using its Mirador360™ engine, which harnesses biology, multi-modal data, AI, and advanced analytics.
What problem does Mirador Therapeutics, Inc. solve?
Today's treatments for immune-mediated inflammatory and fibrotic (I&I) diseases are hitting an efficacy ceiling.
What's Mirador Therapeutics, Inc.'s solution?
Mirador takes a precision-first drug discovery and development approach to identify the right therapeutic targets and the right patients for immuno-fibrotic diseases.
What makes Mirador Therapeutics, Inc. different?
Its proprietary Mirador360 platform is described as an end-to-end precision discovery engine that combines multi-modal data, AI, and advanced analytics to identify novel targets, select optimal combination therapies, and pinpoint likely responders.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
